NCT04257045View on ClinicalTrials.gov

Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives

CompletedOBSERVATIONAL
Enrollment

46

Participants

Timeline

Start Date

August 21, 2019

Primary Completion Date

July 9, 2024

Study Completion Date

July 9, 2024

Conditions
Breast CarcinomaDeleterious CDH1 Gene MutationDeleterious DICER1 Gene MutationDeleterious SMARCA4 Gene MutationDeleterious STK11 Gene MutationEndometrial CarcinomaFallopian Tube CarcinomaOvarian CarcinomaPrimary Peritoneal Carcinoma
Interventions
OTHER

Interview

Participate in semi-structure, in-depth qualitative interviews

OTHER

Questionnaire Administration

Complete questionnaires

OTHER

Survey Administration

Complete survey

Trial Locations (2)

35233

University of Alabama at Birmingham Cancer Center, Birmingham

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT04257045 - Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives | Biotech Hunter | Biotech Hunter